Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Ryan Sullivan, M.D., Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01754376
First received: December 16, 2012
Last updated: March 20, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)